To determine the prognostic and predictive value of intrinsic subtyping by using immunohistochemical ( IHC ) biomarkers for ipsilateral breast relapse ( IBR ) in participants in an early breast cancer randomized trial of tamoxifen with or without breast radiotherapy ( RT ) .